结直肠癌肝转移预测及预后的影像组学综述

doi:10.3969/j.issn.0258-8021.2023.01.010

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (3323 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Colorectal cancer is a cancer disease with high morbidity and mortality at home and abroad. Liver is a main target organ for colorectal cancer metastases. Predicting the occurrence of liver metastasis of colorectal cancer and real-time monitoring the prognostic response of patients is particularly critical to the diagnosis and treatment of the patients. Emerging radiomics offers possibilities for the accurate prediction of liver metastases and prognosis of colorectal cancer. In this paper, existing radiomics studies on colorectal cancer liver metastases (CRLM) were reviewed. Firstly, the clinical significance of CRLM and the limitations of the existing studies were introduced. Secondly, the radiomics analysis process of CRLM was described. Then, four research directions of radiomics on CRLM were reviewed, including predicting the histopathologic growth patterns (HGPs) in CRLM, predicting the hidden liver metastasis, prognosis assessment of liver metastases, and predicting the prognosis of survival in patients with liver metastasis. The latest research progress and challenges in each of the directions were described in detail. Finally, the future development trend of liver metastases radiomics of colorectal cancer was prospected.

Key words： medical image processing radiomics colorectal cancer tumour liver metastases

Received: 26 July 2021

PACS:

R318

Corresponding Authors: ^*E-mail: yjusst@126.com

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Su Xuan
	Wang Yuanjun

Cite this article:

Su Xuan,Wang Yuanjun. Radiomics Review on Prediction and Prognosis of Liver Metastasis in Colorectal Cancer[J]. Chinese Journal of Biomedical Engineering, 2023, 42(1): 91-98.

URL:

http://cjbme.csbme.org/EN/10.3969/j.issn.0258-8021.2023.01.010 OR http://cjbme.csbme.org/EN/Y2023/V42/I1/91

[1] 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
[2] Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics,2020[J].CA Cancer J Clin,2020,70(3):145-164.
[3] Yuan Zixu, Xu Tingyang, Cai Jian, et al. Development and validation of an image-based deep learning algorithm for detection of synchronous peritoneal carcinomatosis in colorectal cancer[J]. Ann Surg,2022,275(4):645-651.
[4] Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019[J].CA Cancer J Clin,2019,69(5):363-385.
[5] 朱德祥,任黎,许剑民.中国结直肠癌肝转移诊断和综合治疗指南(V2020版)[J].中华结直肠疾病电子杂志,2021,10(1):2-25.
[6] Taghavi M, Trebeschi S, Simões R, et al. Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases[J]. Abdom Radiol(NY), 2021, 46(1): 249-256.
[7] Boraschi P, Donati F, Cervelli R, et al. Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response[J]. Eur J Radiol,2021,137:109609.
[8] Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer,2012,48(4):441-446.
[9] 孟霞霞,武志芳,张岩波,等.基于医学影像数据挖掘的肿瘤影像组学研究进展[J].中华核医学与分子影像杂志,2019,39(2):116-120.
[10] 魏炜,刘振宇,王硕,等.影像组学技术研究进展及其在结直肠癌中的临床应用[J].中国生物医学工程学报,2018,37(5):513-520.
[11] Staal FCR, van der Reijd DJ, Taghavi M, et al. Radiomics for the prediction of treatment outcome and survival in patients with colorectal cancer: a systematic review[J]. Clinical Colorectal Cancer,2021,20(1):52-71.
[12] 翁晓燕,蒋恒,季立标,等. IVIM参数与ADC值评估直肠腺癌分化程度的比较[J].磁共振成像,2020,11(7):535-539.
[13] Granata V, Fusco R, Risi C, et al. Diffusion-weighted MRI and diffusion kurtosis imaging to detect RAS mutation in colorectal liver metastasis[J]. Cancers (Basel),2020,12(2420):1-14.
[14] Lambin P, Leijenaar RTH, Deist TM, et al.Radiomics: the bridge between medical imaging and personalized medicine[J].Nat Rev Clin Oncol,2017,14(12):749-762.
[15] 李双双,侯震,刘娟,等.影像组学分析与建模工具综述[J].中国医学物理学杂志,2018,35(9):1043-1049.
[16] Kickingereder P, Burth S, Wick A, et al. Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models[J]. Radiology,2016,280(3):880-889.
[17] Parmar C, Rios Velazquez E, Leijenaar R, et al. Robust radiomics feature quantification using semiautomatic volumetric segmentation[J]. PLoS ONE, 2014,9(7):1-8.
[18] Mackin D, Fave X, Zhang L, et al. Measuring computed tomography scanner variability of radiomics features[J]. Invest Radiol,2015,50(11):757-765.
[19] Van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype[J]. Cancer Res,2017,77(21):104-107.
[20] Liang Cuishan, Huang Yanqi, He Lan, et al. The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer[J].Oncotarget,2016,7(21):31401-31412.
[21] Han Yuqi, Fan Chai, Wei Jingwei, et al. Identification of predominant histopathological growth patterns of colorectal liver metastasis by multi-habitat and multi-sequence based radiomics analysis[J]. Front Oncol,2020,10(1363):1-12.
[22] Ma Xiaolu, Shen Fu, Jia Yan, et al. MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features[J]. BMC Medical Imaging,2019,19(1):1-7.
[23] 舒震宇,方松华,邵园,等.基于T2WI图像的影像组学列线图预测直肠癌同步肝转移的价值[J].中华放射学杂志,2019,53(3):205-211.
[24] Fiz F, Viganò L, Gennaro N, et al. Radiomics of liver metastases: a systematic review[J]. Cancers(Basel),2020,12(10):1-21.
[25] Cheng Jin, Wei Jingwei, Tong Tong, et al. Prediction of histopathologic growth patterns of colorectal liver metastases with a noninvasive imaging method[J]. Ann Surg Oncol,2019,26(13):4587-4598.
[26] Starmans MPA, Buisman FE, Renckens M, et al. Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study [J]. Clin Exp Metastasis,2021,38:483-494.
[27] Liang Meng, Cai Zhengting, Zhang Hongmei, et al. Machine learning-based analysis of rectal cancer MRI radiomics for prediction of metachronous liver metastasis[J]. Academic Radiology, 2019,26(11):1495-1504.
[28] Shu Zhenyu, Fang Songhua, Ding Zhongxiang, et al. MRI-based radiomics nomogram to detect primary rectal cancer with synchronous liver metastases[J]. Sci Rep, 2019,9(3374):1-10.
[29] Li Yue, Gong Jing, Shen Xigang, et al. Assessment of primary colorectal cancer CT radiomics to predict metachronous liver metastasis [J]. Frontiers in Oncology,2022,12:1-8.
[30] Zhu Haibin, Xu Da, Ye Meng, et al. Deep learning-assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases[J]. Int J Cancer, 2021,148(7):1717-1730.
[31] Wei Jingwei, Cheng Jin, Gu Dongsheng, et al. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases[J]. Med Phys,2021,48(1):513-522.
[32] Nakanishi R, Oki E, Hasuda H, et al. Radiomics texture analysis for the identification of colorectal liver metastases sensitive to first-line oxaliplatin-based chemotherapy[J]. Ann Surg Oncol,2021,28(6):2975-2985.
[33] Lambin P, Leijenaar R, Deist T, et al. Radiomics: the bridge between medical imaging and personalized medicine[J]. Nat Rev Clin Oncol,2017,14:749-762.
[34] Van Dam PJ, Van Der Stok EP, Teuwen LA, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis[J]. Br J Cancer.2017,117(10):1427-1441.
[35] Galjart B, Nierop PMH, Van Der Stok EP, et al. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases [J]. Angiogenesis,2019,22:355-368.
[36] Barimani D, Kauppila JH, Sturesson C, et al. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review[J]. World J Surg Oncol,2020,18(264):1-9.
[37] Shur J, Orton M, Connor A, et al. A clinical-radiomic model for improved prognostication of surgical candidates with colorectal liver metastases[J]. J Surg Onco,2020,121:357-364.
[38] Nakai Y, Gonoi W, Kurokawa R, et al. MRI findings of liver parenchyma peripheral to colorectal liver metastasis:a potential predictor of long-term prognosis[J]. Radiology,2020,297(3):584-594.
[39] Dohan A, Gallix B, Guiu B, et al. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab[J].Gut,2020,69(3):531-539.
[40] Rahmim A, Bak-Fredslund KP, Ashrafinia S, et al. Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features[J]. Eur J Radiol,2019,113(2019):101-109.
[41] Andersen IR, Thorup K, Andersen MB, et al. Texture in the monitoring of regorafenib therapy in patients with colorectal liver metastases[J]. Acta Radiol, 2019,60(9):1084-1093.
[42] Ravanelli M, Agazzi GM, Tononcelli E, et al. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy[J]. Radiol Med,2019,124(9):877-886.
[43] Dercle L, Lu L, Schwartz LH, et al. Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway[J]. J Natl Cancer Inst,2020,112(9):902-912.
[44] Van Helden EJ, Vacher YJL, Van Wieringen WN, et al. Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment[J].Eur J Nucl Med Mol Imaging,2018,45(13):2307-2317.
[45] Beckers RCJ, Trebeschi S, Maas M, et al. CT texture analysis in colorectal liver metastases and the surrounding liver parenchyma and its potential as an imaging biomarker of disease aggressiveness, response and survival[J]. Eur J Radiol,2018,102(2018):15-21.
[46] Zwanenburg A, Vallières M, Abdalah MA, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping [J]. Radiology, 2020,295(2):328-338.
[47] Qiu Qingtao, Duan Jinghao, Duan Zuyun, et al. Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: impact of tumor segmentation variability[J]. Quant Imaging Med Surg,2019,9(3):453-464.
[48] Kumar V, Gu Y, Basu S, et al. Radiomics:the process and the challenges[J]. Magn Reson Imaging,2012,30(9):1234-1248.
[49] Lubner MG, Stabo N, Lubner SJ, et al. Volumetric versus unidimensional measures of metastatic colorectal cancer in assessing disease response[J]. Clin Colorectal Cancer,2017,16(4):324-333.
[50] McHugh DJ, Porta N, Little RA, et al. Image contrast,image pre-processing, and T1 mapping affect MRI radiomic feature repeatability in patients with colorectal cancer liver metastases[J].Cancers (Basel),2021,13(240):1-21.